Recombinant human interleukin 2 has emerged as a significant factor in immune therapy for a range Recombinant Human IL-2 of malignancies . This extensive review investigates its process of action , encompassing its function in stimulating T-cell growth and natural killer cell response. We also discuss practical implementations, obstacles, and emerg